ZA902393B - Intranasal administration of physostigmine and arecoline - Google Patents

Intranasal administration of physostigmine and arecoline

Info

Publication number
ZA902393B
ZA902393B ZA902393A ZA902393A ZA902393B ZA 902393 B ZA902393 B ZA 902393B ZA 902393 A ZA902393 A ZA 902393A ZA 902393 A ZA902393 A ZA 902393A ZA 902393 B ZA902393 B ZA 902393B
Authority
ZA
South Africa
Prior art keywords
arecoline
physostigmine
intranasal administration
intranasal
administration
Prior art date
Application number
ZA902393A
Other languages
English (en)
Inventor
Munir Alwan Hussain
Alwan Hussain Munir
Joseph A Mollica
A Mollica Joseph
Original Assignee
Point Merde Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Point Merde Pharmaceuticals Co filed Critical Point Merde Pharmaceuticals Co
Publication of ZA902393B publication Critical patent/ZA902393B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA902393A 1989-03-28 1990-03-28 Intranasal administration of physostigmine and arecoline ZA902393B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32993289A 1989-03-28 1989-03-28

Publications (1)

Publication Number Publication Date
ZA902393B true ZA902393B (en) 1991-11-27

Family

ID=23287646

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902393A ZA902393B (en) 1989-03-28 1990-03-28 Intranasal administration of physostigmine and arecoline

Country Status (13)

Country Link
EP (1) EP0389975A1 (hu)
JP (1) JPH02286618A (hu)
KR (1) KR900013966A (hu)
AU (1) AU5226290A (hu)
CA (1) CA2012192A1 (hu)
FI (1) FI901555A0 (hu)
HU (1) HUT54044A (hu)
IE (1) IE901106L (hu)
IL (1) IL93901A0 (hu)
NO (1) NO901421D0 (hu)
NZ (1) NZ233086A (hu)
PT (1) PT93574A (hu)
ZA (1) ZA902393B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011238B1 (ru) * 2007-04-03 2009-02-27 Марвел Лайфсайнсез Лтд. Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4647580A (en) * 1985-07-18 1987-03-03 Syntex (U.S.A.) Inc. Treatment of Alzheimer's disease

Also Published As

Publication number Publication date
NO901421D0 (no) 1990-03-28
IE901106L (en) 1990-09-28
HU901876D0 (en) 1990-08-28
IL93901A0 (en) 1990-12-23
JPH02286618A (ja) 1990-11-26
CA2012192A1 (en) 1990-09-28
AU5226290A (en) 1990-10-04
HUT54044A (en) 1991-01-28
KR900013966A (ko) 1990-10-22
EP0389975A1 (en) 1990-10-03
NZ233086A (en) 1991-06-25
PT93574A (pt) 1991-01-08
FI901555A0 (fi) 1990-03-28

Similar Documents

Publication Publication Date Title
IL98618A0 (en) Improved ointment base and method of use
GB9106794D0 (en) Covering article and method of making-up thereof
JPS6447796A (en) Alkylglucoside and manufacture
EP0556888A3 (en) Large ceramic article and method of manufacturing
KR950014543B1 (en) Echoelimination and euqalization of telecommunication
GB2267529B (en) Doors and methods of forming doors
IL98074A0 (en) Recombinant production of hirudins and novel hirudins
GB2234994B (en) Paving and facing bricks
EP0362458A3 (en) Can top opening assembly and method of making same
ZA898741B (en) Use of azepinone derivatives
ZA902393B (en) Intranasal administration of physostigmine and arecoline
GB2289708B (en) Doors and Methods of Forming Doors
GB8802421D0 (en) Set of parts
EP0428351A3 (en) Synthesis of quinoline and substituted quinoline copolymers
JPS6450846A (en) Arylbisperfluoroalkylcarbinol and manufacture of same
GB8926745D0 (en) Preparation of omeprazole
GB2237829B (en) Designed article of planar form
GB8920147D0 (en) Doorways and other points of access
JPS6470491A (en) Production of ethodolac and intermediate used therein
ZA893656B (en) Constructional elements and methods of manufacturing such elements
CA60659S (en) Set of jewellery
IE893670L (en) Use of azepinone derivatives
CA66951S (en) Set of jewellery
IE860485L (en) Combination of flupirtin and anticholinergic spasmolytics
CA62968S (en) Set of furniture